share_log

AIM ImmunoTech(AIM.US)董事增持3.85万股普通股股份,价值约1.5万美元

AIM ImmunoTech(AIM.US) Director Buys US$15,000.18 in Common Stocks

Futu News ·  Mar 23 02:10

$AIM ImmunoTech (AIM.US)$ Director BRYAN NANCY purchased 38,462 shares of Common Stocks on Mar 21, 2024 at an average price of $0.39 for a total value of $15,000.18.

1711131055877548477.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment